
Nicolas Musi
Director, Diabetes and Aging Center · Cedars-Sinai Medical Center
Credentials: · · · ·
History
PresentDiabetes and Aging Center · Cedars-Sinai Medical Center
- 1998–2000
Endocrinology, Diabetes, and Metabolism
- 1991–1995
Research
Role of AMP-activated protein kinase in mechanism of metformin action
Journal of Clinical Investigation · 2001 · 4,592 citations
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
EBioMedicine · 2019 · 1,019 citations
Annals of Internal Medicine · 2016 · 818 citations

51 papers

26 papers

19 papers
- EC
16 papers

15 papers

12 papers
- AK
11 papers

11 papers · 6 as a resident
Grants
- 2025–2030
Los Angeles Claude D. Pepper Older Americans Independence Center
National Institute on Aging · P30
Project lead · $386.3K · Cedars-Sinai Medical Center
- 2024–2029
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin
National Institute on Aging · R01
PI · $2.3M · Cedars-Sinai Medical Center
- 2021–2027
National Institute on Aging · U54
PI · $13.8M · University of Connecticut Sch of Med/Dnt
- 2022–2027
National Institute on Aging · R01
Contact PI · $3.4M · Cedars-Sinai Medical Center
Clinical trials
- 2023–2028
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Principal investigator · Recruiting · Phase 2, Phase 3
Cedars-Sinai Medical Center
- 2020–2023
Senolytic Therapy to Modulate Progression of Alzheimer's Disease
Principal investigator · Completed · Phase 1, Phase 2
The University of Texas Health Science Center at San Antonio
- 2015–2018
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects
Principal investigator · Terminated · Phase 2
The University of Texas Health Science Center at San Antonio
- 2015–2018
The Role of TLR4 on Lipid-induced Insulin Resistance
Principal investigator · Completed · Phase 2
The University of Texas Health Science Center at San Antonio

